SCHEMBL9968958

SCHEMBL9968958

CN1C(=O)c2ccc3c4ccc5c6ccc7c8ccc9c%10c(ccc(c%11ccc(c%12ccc(c%13ccc(c2c3%13)C1=O)c4c5%12)c6c7%11)c%108)C(=O)N(C)C9=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 7/20 0.56
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
ALDH1A1 P00352 4/20 0.53
USP2 O75604 2/20 0.53
KEAP1 Q14145 2/20 0.53
NFE2L2 Q16236 2/20 0.53
HPGD P15428 2/20 0.53
ATM Q13315 1/20 0.53
KDM4E B2RXH2 1/20 0.53
STAT3 P40763 1/20 0.53
HIF1A Q16665 1/20 0.53
POLB P06746 1/20 0.50
PRMT1 Q99873 1/20 0.50
CASP3 P42574 1/20 0.45
L3MBTL1 Q9Y468 3/20 0.41
MAPT P10636 2/20 0.41
HSD17B10 Q99714 2/20 0.41
ALOX15 P16050 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9968962 1.00 TERT (0.56) TERTMEN1KMT2AALDH1A1USP2
SCHEMBL29355182 1.00 TERT (0.56) TERTMEN1KMT2AALDH1A1USP2
SCHEMBL710594 1.00 TERT (0.56) TERTMEN1KMT2AALDH1A1USP2
SCHEMBL12170761 1.00 TERT (0.56) TERTMEN1KMT2AALDH1A1USP2
SCHEMBL30937815 0.90 MEN1 (0.55) TERTMEN1KMT2AALDH1A1USP2
SCHEMBL127059 0.90 MEN1 (0.55) TERTMEN1KMT2AALDH1A1USP2
SCHEMBL12748863 0.90 TERT (0.49) TERTMEN1KMT2AALDH1A1USP2
SCHEMBL12449220 0.90 MEN1 (0.54) TERTMEN1KMT2AALDH1A1USP2
SCHEMBL18500360 0.90 TERT (0.49) TERTMEN1KMT2AALDH1A1USP2
SCHEMBL9968961 0.90 TERT (0.49) TERTMEN1KMT2AALDH1A1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9508938-B2 Organic compound and photovoltaic device comprising the same CRYSCADE SOLAR LIMITED (CY) 2016-11-29 US disclosed
US-9508938-B2 Organic compound and photovoltaic device comprising the same CRYSCADE SOLAR LIMITED (CY) 2016-11-29 US disclosed
US-20160043328-A1 ORGANIC COMPOUND AND PHOTOVOLTAIC DEVICE COMPRISING THE SAME CRYSCADE SOLAR LIMITED (CY) 2016-02-11 US disclosed
US-20160043328-A1 ORGANIC COMPOUND AND PHOTOVOLTAIC DEVICE COMPRISING THE SAME CRYSCADE SOLAR LIMITED (CY) 2016-02-11 US disclosed
US-9193727-B2 Organic compound and photovoltaic device comprising the same CRYSCADE SOLAR LIMITED (CY) 2015-11-24 US disclosed
US-9193727-B2 Organic compound and photovoltaic device comprising the same CRYSCADE SOLAR LIMITED (CY) 2015-11-24 US disclosed
US-8481736-B2 Liquid crystalline rylene tetracarboxylic acid derivatives and use thereof BASF SE (DE) 2013-07-09 US disclosed
US-20120227802-A1 ORGANIC COMPOUND AND PHOTOVOLTAIC DEVICE COMPRISING THE SAME CRYSCADE SOLAR LIMITED (CY) 2012-09-13 US disclosed
US-20120227802-A1 ORGANIC COMPOUND AND PHOTOVOLTAIC DEVICE COMPRISING THE SAME CRYSCADE SOLAR LIMITED (CY) 2012-09-13 US disclosed
WO-2012122312-A1 ORGANIC COMPOUND AND PHOTOVOLTAIC DEVICE COMPRISING THE SAME CRYSCADE SOLAR LIMITED (CY) 2012-09-13 WO disclosed
US-8202994-B2 Pentarylene- and hexarylenetetracarboximides and preparation thereof BASF AKTIENGESELLSCHAFT (DE) 2012-06-19 US disclosed
US-20110042651-A1 LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF BASF SE (DE) 2011-02-24 US disclosed
US-20100059716-A1 PENTARYLENE-AND HEXARYLENETETRACARBOXIMIDES AND PREPARATION THEREOF BASF SE (DE) 2010-03-11 US disclosed
US-7625497-B2 Materials and methods for the preparation of anisotropically-ordered solids BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, RENO (US) 2009-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110042651-A1 LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF TPR, ROR1, CA3 TERT 501/4885MEN1 1342/4885KMT2A 3067/4885
US-20100059716-A1 PENTARYLENE-AND HEXARYLENETETRACARBOXIMIDES AND PREPARATION THEREOF CYP2C9, PNPO, CYP3A43 TERT 1767/4885MEN1 1512/4885KMT2A 3106/4885
US-20160043328-A1 ORGANIC COMPOUND AND PHOTOVOLTAIC DEVICE COMPRISING THE SAME CORO1C, SUN2, VDAC1 TERT 964/4885MEN1 601/4885KMT2A 3701/4885
US-20120227802-A1 ORGANIC COMPOUND AND PHOTOVOLTAIC DEVICE COMPRISING THE SAME SUN2, CORO1C, CORO1A TERT 776/4885MEN1 498/4885KMT2A 3084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.